Dr. Stefan Sarafianos, a professor of Molecular Microbiology and Immunology at the University of Missouri, was recently awarded a research grant of $3 million from the National Institutes of Health to develop new drugs to treat Hepatitis B (HBV).
Read MoreScience Market Update
Tags: MO, University of Missouri, Columbia, University of Missouri, MU, Missouri, Midwest Region, NIH award, Hepatitis B, Drug Development